Detalhe da pesquisa
1.
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
Oncologist
; 29(1): e141-e151, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463014
2.
Low plasma PD-L1 levels, early tumor onset and absence of peritoneal carcinomatosis improve prognosis of women with advanced high-grade serous ovarian cancer.
BMC Cancer
; 23(1): 437, 2023 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37179293
3.
Clinical relevance of exosome-derived microRNAs in Ovarian Cancer: Looking for new tumor biological fingerprints.
Crit Rev Oncol Hematol
; 193: 104220, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036154
4.
Potential agnostic role of BRCA alterations in patients with several solid tumors: One for all, all for one?
Crit Rev Oncol Hematol
; 190: 104086, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536445
5.
Prognostic role of soluble PD-1 and BTN2A1 in overweight melanoma patients treated with nivolumab or pembrolizumab: finding the missing links in the symbiotic immune-metabolic interplay.
Ther Adv Med Oncol
; 15: 17588359231151845, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36818688
6.
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab.
Front Oncol
; 13: 1141500, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37139149
7.
Theranostic biomarkers and PARP-inhibitors effectiveness in patients with non-BRCA associated homologous recombination deficient tumors: Still looking through a dirty glass window?
Cancer Treat Rev
; 121: 102650, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939446
8.
BRCA1/2 variants of unknown significance in hereditary breast and ovarian cancer (HBOC) syndrome: Looking for the hidden meaning.
Crit Rev Oncol Hematol
; 172: 103626, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150867
9.
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength.
Front Oncol
; 12: 827822, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35223509
10.
MUTYH-associated tumor syndrome: The other face of MAP.
Oncogene
; 41(18): 2531-2539, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35422474
11.
Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer.
Cancers (Basel)
; 14(18)2022 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36139508
12.
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Front Oncol
; 12: 946319, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212445
13.
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
Crit Rev Oncol Hematol
; 170: 103597, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35033663
14.
Exploring the Dynamic Crosstalk between the Immune System and Genetics in Gastrointestinal Stromal Tumors.
Cancers (Basel)
; 15(1)2022 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612211
15.
Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology.
Crit Rev Oncol Hematol
; 159: 103246, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545354
16.
POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes.
Oncogene
; 40(40): 5893-5901, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363023
17.
Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors.
Crit Rev Oncol Hematol
; 163: 103390, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34090998
18.
Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?
Cancers (Basel)
; 13(9)2021 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33925671
19.
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
Front Oncol
; 11: 682445, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34178674
20.
Not all KIT 557/558 codons mutations have the same prognostic influence on recurrence-free survival: breaking the exon 11 mutations in gastrointestinal stromal tumors (GISTs).
Ther Adv Med Oncol
; 13: 17588359211049779, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34616493